North America Organ Care Products Market

The organ care products market in North America is expected to grow from US$ 40.72 million in 2021 to US$ 114.36 million by 2028; it is estimated to grow at a CAGR of 15.9% from 2021 to 2028.

 

The US, Canada, and Mexico are major economies in North America. There has been a constant increase in organ failure incidence across the region, owing to various chronic health conditions such as cardiovascular disorders, genetic conditions, and diabetes. As per Health Resources and Service Administration report 2020, 106,247 people, including men, women, and children, are on the national transplant waiting list. Every 9 minutes, another person is added to the transplant list in the US. Thus, the rising incidence of organ failure has created the demand for organ transplant procedures, which, in turn, is driving the organ care products market.

Over the period, there has been a significant increase in organ donation, owing to a rise in awareness among people and rapidly developing health facilities. According to the Health Resources and Service Administration report 2020, 22,817 kidney transplantations have been performed in the US, accounting for 83% of the total transplant procedures in the US. Furthermore, development in healthcare facilities to enhance the success rates of transplant procedures and reduce organ rejection rates has increased the organ transplantation procedures, fueling the demand for organ care products and contributing to the growth of organ care products markets

 

On the other hand, timing, storage, and transportation have an important role in transplant procedures, especially in the case of circulatory death. Timely removal of organs, transportation, and implantation are expected to increase the success rates; this requires efficient organ care products to keep the organ safe until implantation. For this purpose, several market players such as TransMedics and OrganOx Limited have designed various systems with advanced technology to keep the organs safe, eliminating the use of organ transport cooler boxes. For instance, TransMedics Group, Inc. has launched its organ care system, which allows the beating donor heart to be maintained in a warm (34°C) perfused oxygenated state during the transfer from donor to recipient hospitals. This allows for an extended “out of body” time and minimizes the detrimental effects of cold ischemic storage. Moreover, technological advancements in organ care products and the high adoption rate among healthcare professionals due to the increase in reliability, convenience, and portability drive the organ care products market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America organ care products market. The North America organ care products market is expected to grow at a good CAGR during the forecast period.

 

North America Organ Care Products

Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report Request Free Sample PDF

North America Organ Care Products Strategic Insights

Strategic insights for the North America Organ Care Products provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Organ Care Products Report Scope

North America Organ Care Products Regional Insights

The geographic scope of the North America Organ Care Products refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Organ Care Products Market Segmentation

The North America organ care products market is segmented into modality, organ type, end user, and country. Based on modality, the market is segmented into trolley and portable. In 2021, the trolley segment held a larger share of the market. In terms of organ type, the market is segmented into kidney, liver, heart, lungs, and others. In 2021, the kidney segment held the largest market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2021, the hospitals segment held the largest share of the market. Based on country, the North America organ care products market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.

Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Organ Recovery Systems; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are among the leading companies in the North America organ care products market.